Batrinos M L, Pavlou S N, Pitoulis S A, Sfikaki A P, Alexandrides T K, Piaditis G P
Clin Endocrinol (Oxf). 1978 Mar;8(3):193-6. doi: 10.1111/j.1365-2265.1978.tb01494.x.
The results obtained with a new test of prolactin (PRL) release in six panhypopituitary patients as compared to fourteen normal subjects (eight females and six males) are presented. The test consists of the i.m. administration of 100 mg of sulpiride and the measurement of plasma PRL by a double antibody radioimmunoassay techniques at--15, 0, 15, 30, 45, 60, 75, 90, 105 and 120 min. Mean baseline PRL values were not significantly different in the three groups. After sulpiride a 800-4200% increment of prolactin over control values was noted in the females and 1200-3500% increment in the males. The peak values were obtained at 15 or 30 min (6030+/-670 mu/l +/-SEM in the females and 5550+/-870 mu/l in the males). The mean values were not significantly different in the two sexes until the sixtieth minute but were significantly higher (P less than 0.05) in the female thereafter. In the hypopituitary patients a complete failure of response was noted. These results show that the sulpiride test possesses a considerable potential as a screening procedure in the diagnosis of pituitary insufficiency.
本文展示了对6例全垂体功能减退患者以及14名正常受试者(8名女性和6名男性)进行催乳素(PRL)释放新测试的结果。该测试包括肌肉注射100毫克舒必利,并采用双抗体放射免疫分析技术在-15、0、15、30、45、60、75、90、105和120分钟时测量血浆PRL。三组的平均基础PRL值无显著差异。注射舒必利后,女性的催乳素水平比对照值增加了800%-4200%,男性增加了1200%-3500%。峰值出现在15或30分钟时(女性为6030±670μl±SEM,男性为5550±870μl)。直到第60分钟,两性的平均值无显著差异,但此后女性的值显著更高(P<0.05)。在垂体功能减退患者中,观察到完全无反应。这些结果表明,舒必利测试在垂体功能不全的诊断中作为一种筛查程序具有相当大的潜力。